Contraceptives Market By Product 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Contraceptives Market
Contraceptives Market: By Product (Drug, Devices); By End-User (Hospital, Clinic, Home Care, Ambulatory Surgical Centre) & By Region (Europe, Asia-Pacific, North America, RoW)-Forecast (2016-2022)
Report Code : HCR 0411
Updated Date: 15 September, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Contraceptives Market – Overview
2. Executive Summary
3. Contraceptives Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Contraceptives Market– Forces
   4.1. Drivers
      4.1.1. Increasing awareness about STDs and Population control
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Contraceptives Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Contraceptives Market, By Product
   6.1. Drug
      6.1.1. Oral Contraceptive
      6.1.2. Injectible
      6.1.3. Topical
   6.2. Devices
      6.2.1. Condom
            6.2.1.1. Male
            6.2.1.2. Female
      6.2.2. Diaphragms
      6.2.3. Sponges
      6.2.4. Vaginal Ring
      6.2.5. Subdermal Implants
      6.2.6. Intrauterine Devices
            6.2.6.1. Male
            6.2.6.2. Female
7. Contraceptives Market, By End-User
   7.1. Hospital
   7.2. Clinic
   7.3. Home Care
   7.4. Ambulatory Surgical Centre
   7.5. Others
8. Contraceptives Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Contraceptives Market – Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Cooper Surgical, Inc.
   10.2. Bayer AG
   10.3. Actavis, Inc.
   10.4. The Female Health Company
   10.5. Merck & Co., Inc.
   10.6. Mayer Laboratories, Inc.
   10.7. Pfizer, Inc.
   10.8. Church & Dwight, Co., Inc.
   10.9. Medisafe Distribution Inc.
   10.10. Teva Pharmaceutical Industries Limited
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Contraception can be defined as the deliberate prevention of pregnancy by interfering with the normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques and the devices used for contraception are called as contraceptives. Contraceptives drugs or devices not only inhibit pregnancy, but also sexually transmitted diseases (STDs). Globally, increasing awareness about STD and population control measures are expected to be the key growth drivers for the contraceptives market during the period of study.

 Contraceptives Market
 
Geographically, North America dominated the contraceptives market driven by higher demand and consumption of contraceptives due to higher awareness about its benefits and population control in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the contraceptives market. Asia Pacific is projected to have the fastest growth, owing to rapidly growing awareness amongst people in the region about contraceptives and initiatives by governments in developing nations such as China and India to educate people to control population in two most populated nations in the world.

This report identifies the contraceptives market size for the years 2014-2016, and forecast of the same till year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the contraceptives market.

This report segments the contraceptives market on the basis of product, end-user and regional market as follows:
  • Contraceptives market research report is classified on the basis of product. Some of the major products covered in this report are as follows: Drug (Oral Contraceptive, Injectible, Topical), Devices (Condom (Male, Female), Diaphragms, Sponges, Vaginal Ring, Subdermal Implants, Intrauterine Devices (Male, Female))
  • Contraceptives market research report is classified on the basis of end-user. Some of the major end-users covered in this report are as follows: Hospital, Clinic, Home Care, Ambulatory Surgical Centre (ASC) and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the contraceptives market. Some of the major companies’ profiles in detail are as follows:
  • The Female Health Company
  • Merck & Co., Inc.
  • Mayer Laboratories, Inc.
  • Church & Dwight, Co., Inc..
  • Teva Pharmaceutical Industries Limited

Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll